Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naïve advanced or metastatic esophagogastric cancer
Crossref DOI link: https://doi.org/10.1007/s10120-016-0618-0
Published Online: 2016-06-02
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moehler, Markus
Mahlberg, Rolf
Heinemann, Volker
Obermannová, Radka
Kubala, Eugen
Melichar, Bohuslav
Weinmann, Arndt
Scigalla, Paul
Tesařová, Marietta
Janda, Petr
Hédouin-Biville, Fabienne
Mansoor, Wasat
License valid from 2016-06-02